C4 Therapeutics, Inc. (CCCC) (CIK 0001662579) CORRESP
A CORRESP letter is the company's written reply to the SEC during a filing review. Responses include accounting position arguments, restatement assessments, and clarifying disclosures. Released to EDGAR alongside the SEC's UPLOAD letters.
Key facts
- Accession number
- 0001628280-25-055804
- Form
- CORRESP
- Filer
- C4 Therapeutics, Inc. (CCCC) (CIK 0001662579)
- CIK
- 0001662579
- Ticker
- CCCC
- Filed
- 2025-12-08
- SIC industry
- 2836
- HQ
- Watertown, MA
Primary source
PDF letter: https://www.sec.gov/Archives/edgar/data/1662579/000162828025055804/filename1.htm
EDGAR review index: browse all UPLOAD/CORRESP for this filer ↗